✦ LIBER ✦

Interference effects in neutron scattering on protons in a double minimum potential

✍ Scribed by C. Schenk; B. Weckermann

Publisher: Elsevier Science
Year: 1968
Tongue: English
Weight: 195 KB
Volume: 27
Category: Article
ISSN: 0375-9601
DOI: 10.1016/0375-9601(68)90061-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemical binding effects in resonance—Po

Chemical binding effects in resonance—Potential interference scattering for harmonic crystals

✍ A. Kuwaifi; G.C. Summerfield 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Neutron and proton scattering from the s

Neutron and proton scattering from the same nucleus as a means of determining the isospin term in the optical potential

✍ P.E. Hodgson 📂 Article 📅 1963 🏛 Elsevier Science ⚖ 230 KB

Change of the proton potential from a si

Change of the proton potential from a single to a double minimum in intramolecular hydrogen bonds with increasing pKa of the phenolic group in 4-R-Mannich base N-oxides

✍ Bogumił Brzezinski; Jerzy Olejnik; Georg Zundel; Rainer Krämer 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 386 KB

The effect of a non-Hermitian crystal po

The effect of a non-Hermitian crystal potential on the scattering matrix in reflection electron diffraction

✍ A.E. Smith; T.W. Josefsson 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 356 KB

On the elastic and inelastic Mossbauer e

On the elastic and inelastic Mossbauer effect for impurity atoms in a crystal and the effect of such atoms on neutron scattering

✍ I. Waller 📂 Article 📅 1963 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Effect of ultrahigh-dose methylcobalamin

Effect of ultrahigh-dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: A double-blind controlled study

✍ Ryuji Kaji; Mitsuo Kodama; Atsuko Imamura; Thoru Hashida; Nobuo Kohara; Masahiro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

To develop a symptomatic treatment for amyotrophic lateral sclerosis, we compared the effects of ultrahigh-dose and low-dose (25 and 0.5 mg/day, intramuscularly, for 14 days) methylcobalamin on averaged compound muscle action potential amplitudes (CMAPs) in a double-blind trial. No significant chang